Challenges Facing the Cancer Care Delivery System
Click here to read the full presentation given at the Cancer Support Community 2018 Health Care Partner Seminar on June 14, 2018 in Washington, DC.
Charting a Path Forward for the Oncology Care Model
The Oncology Care Model (OCM) is a Federal health reform program that aims to change the way cancer care in America is delivered. Its goal? To provide high quality, well-coordinated cancer care to patients while reducing costs for Medicare and beneficiaries. Eager to be involved in the future of cancer care, nearly
How Abuse of the 340B Program is Hurting Patients
The 340B Drug Discount program exemplifies how good ideas, no matter how well-intended, can easily go bad if they fall into the wrong hands and are abused. Ultimately, abuse of the 340B program has begun to harm the very poor, uninsured, and underinsured patients it was meant to serve. 340B is a critically important
MACRA Proposed Rule Summary: Impact for Oncologists
MACRA Proposed Rule Summary: Impact for Oncologists On June 20, 2017, the Centers for Medicare and Medicaid Services (CMS) posted the 2018 Quality Payment Program (QPP) Proposed Rule (CMS-5522-P) which is updated annually as part of the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA). The Community Oncology Alliance
The 340B Program in Review: A Look at the Data and Evidence to Date
Since its inception, the 340B Drug Discount Program has been the subject of countless research studies, white papers, and analyses looking at its substantial growth and role in the United States’ health care system. This paper seeks to provide a review of the data and evidence provided by studies of the 340B program to
February 13: Presentation to the Coalition of Hematology Oncology Practices (CHOP) 2017 Business Summit
Presentation to the Coalition of Hematology Oncology Practices (CHOP) “From Capitol Hill to Fort Worth…Oncology Policy in the Whacky World of Washington, DC” given on February 10, 2017. Click here to download the slides.
February 13: Presentation to the Puerto Rico Oncology Summit
Presentation to the Puerto Rico Oncology Summit “Current Oncology Care Issues...A Look at the USA and Capitol Hill" given on February 4, 2017. Click here to download the slides.
January 23: Presentation to The New Jersey Society of Oncology Managers (NJSOM)
Presentation to the New Jersey Society of Oncology Managers (NJSOM) “From Capitol Hill to Bridgewater…A Crystal Ball Look at Oncology Policy for 2017 and Beyond” given on January 20, 2017. Click here to download the slides
January 19: Presentation to the Midwest Oncology Practice Society (MOPS)
Presentation to the Midwest Oncology Practice Society (MOPS) "From Capitol Hill to Omaha…A Crystal Ball Look at Oncology Policy for 2017 and Beyond" given on January 19, 2017. Click here to download the slides
The Legal and Constitutional Case: Why CMS Did Not Have the Authority to Apply the Sequester Cut to Medicare Part B Drug Reimbursement
For years, the budget of the Obama Administration included a reimbursement payment cut to Medicare Part B drugs, which are generally infusible drugs to treat cancer and other complex, potentially life-threating diseases administered in a clinical setting. However, Congress has fixed Medicare Part B drug reimbursement in statute with the Medicare Modernization Act of
